| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 1-Nov-08 | | Total Revenue | 111,605 | 143,097 | 146,603 | 104,948 | | Cost of Revenue | 69,011 | 85,909 | 90,695 | 66,208 | | | Gross Profit | 42,594 | 57,188 | 55,908 | 38,740 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,994 | 40,133 | 37,409 | 36,482 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,455 | 4,373 | 4,346 | 4,134 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (855) | 12,682 | 14,153 | (1,876) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 776 | (589) | 280 | 790 | | Earnings Before Interest And Taxes | (79) | 12,093 | 14,433 | (1,086) | | Interest Expense | 28 | 41 | 51 | 94 | | Income Before Tax | (107) | 12,052 | 14,382 | (1,180) | | Income Tax Expense | (38) | 4,123 | 4,326 | (493) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (69) | 7,929 | 10,056 | (687) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (69) | 7,929 | 10,056 | (687) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($69) | $7,929 | $10,056 | ($687) |
|
0.51% Nasdaq 
Income Statement
